Moreover, due to its potent effect on gastrointestinal function, it can lead to delayed gastric emptying and alter intestinal motility
Sources: Neeland, Ian J., et al
Barnett R, Gnerre S, Willis J, Overman MJ, Singh Raghav KP, Parseghian CM, Dasari A, Morelli MP, Johnson B, Eluri M, Drusbosky L, Kopetz S , Morris VK
These include: For Weight Loss (GLP-1s) : Wegovy or Zepbound pens (may be covered by certain insurance plans for weight loss) For Type 2 Diabetes (GLP-1s) : Ozempic or Mounjaro pens (may be covered by certain insurance plans only for type 2 diabetes) Compounded Semaglutide: Semaglutide is the active ingredient in Ozempic and Wegovy
Median (IQR) time below range (TBR, 70% at follow-up overall and for younger ( 70% increased from 0% to 37.9% at 6 months and to 43.1% at 1 year
Combined with retatrutide driven fat loss, the theory is that GH would further shift the fat-to-lean mass loss ratio in favor of preserving muscle